Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.462ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.462SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.462NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.462NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.462ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
A.29ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
A.29ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
A.29ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
A.29ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
A.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.29NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
A.29NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
A.29ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-15722.9Japan
B.1.147ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
B.1.147ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
B.1.147ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.147ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.147SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.147NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.147NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.147ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
P.1.6 (Gamma)ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
P.1.6 (Gamma)ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
P.1.6 (Gamma)ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
P.1.6 (Gamma)ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
P.1.6 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.6 (Gamma)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
P.1.6 (Gamma)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
P.1.6 (Gamma)ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
P.1.5 (Gamma)ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
P.1.5 (Gamma)ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
P.1.5 (Gamma)ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
P.1.5 (Gamma)ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
P.1.5 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.5 (Gamma)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
P.1.5 (Gamma)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
P.1.5 (Gamma)ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
P.1.4 (Gamma)ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
P.1.4 (Gamma)ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
P.1.4 (Gamma)ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
P.1.4 (Gamma)ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
P.1.4 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.4 (Gamma)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
P.1.4 (Gamma)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
P.1.4 (Gamma)ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
B.1.420ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
B.1.420ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
B.1.420ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.420ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.420SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used